HN2009000968A - Compuestos de pirazol y triazol sustituidos como inhibidores de ksp - Google Patents
Compuestos de pirazol y triazol sustituidos como inhibidores de kspInfo
- Publication number
- HN2009000968A HN2009000968A HN2009000968A HN2009000968A HN2009000968A HN 2009000968 A HN2009000968 A HN 2009000968A HN 2009000968 A HN2009000968 A HN 2009000968A HN 2009000968 A HN2009000968 A HN 2009000968A HN 2009000968 A HN2009000968 A HN 2009000968A
- Authority
- HN
- Honduras
- Prior art keywords
- pirazol
- ksp inhibitors
- compounds replaced
- triazol compounds
- triazol
- Prior art date
Links
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical class C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE DAN A CONOCER NUEVOS COMPUESTOS DE PIRAZOL Y TRIAZOL SUSTITUIDOS DE LA FORMULA (1), Y SALES FARMASEUTICAMENTE ACEPTABLES, ESTERES O PRO-FARMCOS DE LOS MISMOS, COMPOCISIONES DE LOS DERIVADOS JUNTO CON VEHICULOS FARMACEUTICAMENTE ACEPTABLES , Y USOS DE LOS MISMOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85896406P | 2006-11-13 | 2006-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2009000968A true HN2009000968A (es) | 2011-10-25 |
Family
ID=39144618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2009000968A HN2009000968A (es) | 2006-11-13 | 2009-05-13 | Compuestos de pirazol y triazol sustituidos como inhibidores de ksp |
Country Status (32)
Country | Link |
---|---|
US (2) | US7902240B2 (es) |
EP (1) | EP2091926B1 (es) |
JP (1) | JP5264755B2 (es) |
KR (1) | KR20090081020A (es) |
CN (1) | CN101558049B (es) |
AR (1) | AR063805A1 (es) |
AU (1) | AU2007323998B2 (es) |
BR (1) | BRPI0719002A2 (es) |
CA (1) | CA2668661A1 (es) |
CL (1) | CL2007003272A1 (es) |
CO (1) | CO6382171A2 (es) |
CR (1) | CR10787A (es) |
DO (1) | DOP2009000106A (es) |
EA (1) | EA017748B1 (es) |
EC (1) | ECSP099326A (es) |
ES (1) | ES2557478T3 (es) |
GE (1) | GEP20125389B (es) |
GT (1) | GT200900122A (es) |
HN (1) | HN2009000968A (es) |
IL (1) | IL198471A0 (es) |
MA (1) | MA30959B1 (es) |
MX (1) | MX2009005071A (es) |
NI (1) | NI200900084A (es) |
NO (1) | NO20092226L (es) |
NZ (1) | NZ576640A (es) |
PE (1) | PE20081169A1 (es) |
SM (1) | SMP200900045B (es) |
TN (1) | TN2009000178A1 (es) |
TW (1) | TW200831480A (es) |
UA (1) | UA97256C2 (es) |
WO (1) | WO2008063912A1 (es) |
ZA (1) | ZA200902940B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0719002A2 (pt) * | 2006-11-13 | 2013-12-17 | Novartis Ag | Compostos de pirazol e triazol substituídos como inibidores de ksp |
NZ577727A (en) * | 2007-01-05 | 2012-03-30 | Novartis Ag | Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) |
US8546434B2 (en) * | 2010-04-15 | 2013-10-01 | Novartis Ag | Triazole compounds as KSP inhibitors |
JP2013525290A (ja) * | 2010-04-15 | 2013-06-20 | ノバルティス アーゲー | Ksp阻害剤としてのオキサゾールおよびチアゾール化合物 |
BR112015012843B8 (pt) * | 2012-12-05 | 2023-04-25 | Merck Sharp & Dohme | Método para sintetizar o composto |
US9498540B2 (en) | 2013-03-15 | 2016-11-22 | Novartis Ag | Cell proliferation inhibitors and conjugates thereof |
JP2016516035A (ja) * | 2013-03-15 | 2016-06-02 | ノバルティス アーゲー | 細胞増殖阻害剤およびそれらのコンジュゲート |
EP3077376B1 (en) | 2013-12-04 | 2019-10-16 | Merck Sharp & Dohme Corp. | Process for making reverse transcriptase inhibitors |
US10786578B2 (en) | 2014-08-05 | 2020-09-29 | Novartis Ag | CKIT antibody drug conjugates |
WO2017097927A1 (en) * | 2015-12-11 | 2017-06-15 | Syngenta Participations Ag | Pesticidally active 1,2,4-triazole derivatives |
US11091447B2 (en) | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
US5185450A (en) | 1991-02-19 | 1993-02-09 | University Of South Florida | Tetrazolium compounds for cell viability assays |
AUPP042397A0 (en) * | 1997-11-18 | 1997-12-11 | Fujisawa Pharmaceutical Co., Ltd. | 5-arylpyrazole compounds |
WO2000059887A1 (en) | 1999-04-02 | 2000-10-12 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
DE60028227T2 (de) | 1999-10-27 | 2007-03-29 | Cytokinetics, Inc., South San Francisco | Chinazolinone benutzende verfahren und zusammenstellungen |
CA2425185A1 (en) | 2000-10-06 | 2002-04-11 | Stephane De Lombaert | Benzimidazole and indole derivatives as crf receptor modulators |
US6992082B2 (en) | 2001-01-19 | 2006-01-31 | Cytokinetics, Inc. | Phenothiazine kinesin inhibitors |
US20040132830A1 (en) | 2001-01-19 | 2004-07-08 | Finer Jeffrey T | Triphenylmethane kinesin inhibitors |
US7060705B2 (en) | 2001-11-07 | 2006-06-13 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
TW200300078A (en) | 2001-11-08 | 2003-05-16 | Univ Chicago | Method of treating disorder related to high cholesterol concentration |
WO2003043995A1 (en) | 2001-11-20 | 2003-05-30 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
US7244723B2 (en) | 2001-12-06 | 2007-07-17 | Merck & Co., Inc. | Substituted furopyrimidinones as a mitotic kinesin inhibitors |
US7262187B2 (en) | 2001-12-06 | 2007-08-28 | Merck & Co., Inc. | Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
AU2002363960B2 (en) | 2001-12-06 | 2008-07-10 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
AU2002357053B2 (en) | 2001-12-06 | 2008-05-15 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
CA2468266A1 (en) | 2001-12-06 | 2003-06-19 | Merck & Co., Inc. | Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors |
EP1461027A4 (en) * | 2001-12-07 | 2005-09-07 | Univ Virginia Commonwealth | TREATMENT OF NEOPLASIA |
US6906075B2 (en) | 2002-01-10 | 2005-06-14 | Neurogen Corp. | Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
AU2003213092A1 (en) | 2002-02-15 | 2003-09-09 | Smithkline Beecham Corporation | Syntheses of quinazolinones |
DE60329990D1 (de) | 2002-03-08 | 2009-12-24 | Merck & Co Inc | Mitotische kinesin-hemmer |
WO2003097053A1 (en) | 2002-05-09 | 2003-11-27 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US7166595B2 (en) | 2002-05-09 | 2007-01-23 | Cytokinetics, Inc. | Compounds, methods and compositions |
AU2003290507A1 (en) | 2002-05-10 | 2004-04-08 | Cytokinetics, Inc. | Compounds, compositions and methods |
JP2005536475A (ja) | 2002-05-23 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
AU2003231799A1 (en) | 2002-05-23 | 2003-12-12 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
DE60312516T2 (de) | 2002-06-14 | 2007-11-22 | Merck & Co., Inc. | Inhibitoren von mitotischem kinesin |
EP1515724B1 (en) | 2002-06-14 | 2009-10-21 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
GB0214139D0 (en) * | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
CA2489562A1 (en) | 2002-07-08 | 2004-01-15 | Merck & Co., Inc. | Mitotic kinesin binding site |
JP2005533119A (ja) | 2002-07-17 | 2005-11-04 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、及び方法 |
AU2003256805A1 (en) | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
US20040048853A1 (en) | 2002-08-21 | 2004-03-11 | Gustave Bergnes | Compounds, compositions, and methods |
WO2004024086A2 (en) | 2002-09-13 | 2004-03-25 | Cytokinetics, Inc. | Compounds, compositions and methods |
JP2007500213A (ja) | 2003-05-07 | 2007-01-11 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
US20070032536A1 (en) | 2003-05-15 | 2007-02-08 | Xianping Qian | Compounds, compositions and methods |
US7504405B2 (en) | 2004-04-06 | 2009-03-17 | Novartis Vaccines And Diagnostics, Inc. | Mitotic kinesin inhibitors |
JP2008502721A (ja) | 2004-05-21 | 2008-01-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | ***キネシンインヒビターとしての置換キノリン誘導体 |
BRPI0510929A (pt) * | 2004-06-18 | 2007-07-17 | Chiron Corp | derivados de n-(1-(1-benzil-4-fenil-1h-imidazol-2-il)-2,2-dimetilpropil) benzamida e compostos relacionados como inibidores de proteìna de eixo de kinesin (ksp) para o tratamento de cáncer |
MX2007004699A (es) | 2004-10-19 | 2007-06-14 | Novartis Vaccines & Diagnostic | Derivados de indol y bencimidazol. |
US7829589B2 (en) * | 2005-06-10 | 2010-11-09 | Elixir Pharmaceuticals, Inc. | Sulfonamide compounds and uses thereof |
TW200800951A (en) | 2005-08-09 | 2008-01-01 | Novartis Ag | Substituted imidazole compounds as KSP inhibitors |
BRPI0719002A2 (pt) * | 2006-11-13 | 2013-12-17 | Novartis Ag | Compostos de pirazol e triazol substituídos como inibidores de ksp |
-
2007
- 2007-11-08 BR BRPI0719002-6A patent/BRPI0719002A2/pt not_active IP Right Cessation
- 2007-11-08 UA UAA200904556A patent/UA97256C2/ru unknown
- 2007-11-08 WO PCT/US2007/084154 patent/WO2008063912A1/en active Application Filing
- 2007-11-08 GE GEAP200711253A patent/GEP20125389B/en unknown
- 2007-11-08 CA CA002668661A patent/CA2668661A1/en not_active Abandoned
- 2007-11-08 ES ES07844993.1T patent/ES2557478T3/es active Active
- 2007-11-08 EA EA200900631A patent/EA017748B1/ru not_active IP Right Cessation
- 2007-11-08 AU AU2007323998A patent/AU2007323998B2/en not_active Ceased
- 2007-11-08 US US11/937,426 patent/US7902240B2/en not_active Expired - Fee Related
- 2007-11-08 CN CN2007800456741A patent/CN101558049B/zh not_active Expired - Fee Related
- 2007-11-08 JP JP2009536490A patent/JP5264755B2/ja not_active Expired - Fee Related
- 2007-11-08 KR KR1020097012214A patent/KR20090081020A/ko not_active Application Discontinuation
- 2007-11-08 US US12/312,389 patent/US8129358B2/en not_active Expired - Fee Related
- 2007-11-08 NZ NZ576640A patent/NZ576640A/en not_active IP Right Cessation
- 2007-11-08 EP EP07844993.1A patent/EP2091926B1/en active Active
- 2007-11-08 MX MX2009005071A patent/MX2009005071A/es active IP Right Grant
- 2007-11-12 TW TW096142719A patent/TW200831480A/zh unknown
- 2007-11-13 CL CL200703272A patent/CL2007003272A1/es unknown
- 2007-11-13 PE PE2007001561A patent/PE20081169A1/es not_active Application Discontinuation
- 2007-11-13 AR ARP070105052A patent/AR063805A1/es unknown
-
2009
- 2009-04-29 ZA ZA200902940A patent/ZA200902940B/xx unknown
- 2009-04-30 IL IL198471A patent/IL198471A0/en unknown
- 2009-05-08 CR CR10787A patent/CR10787A/es not_active Application Discontinuation
- 2009-05-08 TN TNP2009000178A patent/TN2009000178A1/fr unknown
- 2009-05-11 DO DO2009000106A patent/DOP2009000106A/es unknown
- 2009-05-12 GT GT200900122A patent/GT200900122A/es unknown
- 2009-05-12 CO CO09048059A patent/CO6382171A2/es not_active Application Discontinuation
- 2009-05-13 EC EC2009009326A patent/ECSP099326A/es unknown
- 2009-05-13 HN HN2009000968A patent/HN2009000968A/es unknown
- 2009-05-13 NI NI200900084A patent/NI200900084A/es unknown
- 2009-06-01 MA MA31938A patent/MA30959B1/fr unknown
- 2009-06-09 NO NO20092226A patent/NO20092226L/no not_active Application Discontinuation
- 2009-06-10 SM SM200900045T patent/SMP200900045B/it unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2009000968A (es) | Compuestos de pirazol y triazol sustituidos como inhibidores de ksp | |
CR20140215A (es) | Ciclopenta (d) pirimidinas como inhibidores de la proteina cinasa akt | |
CU23834B1 (es) | Compuestos de pirazolo [3,4-d] pirimidinona y sus derivados para la inhibición pde9 | |
CR11518A (es) | Compuestos de carbamoilo como inhibidores de dgat1 190 | |
NI201000041A (es) | Derivados y composiciones que comprenden quinazolinona 6-, 7-, u 8 - sustituida y métodos para utilizar la misma. | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
AR062745A1 (es) | 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol como inhibidor de quinasa | |
CR11229A (es) | Pirimidil ciclopentanos como inhibidores de proteina cinasa akt | |
CR8744A (es) | Compuestos terapeuticos | |
NI200900040A (es) | Derivados de quinazolinona 5-substituidos como agentes antitumorales. | |
CR20140368A (es) | Derivados y composiciones de isoindol 4´-0-sustituidos, composiciones que las comprenden y metodos de uso de los mismos (divisional 11036) | |
ECSP10010246A (es) | Inhibidores de beta-lactamasa | |
NI201000085A (es) | Derivados bis - (sulfonilamino) en terapia 066. | |
ECSP10010272A (es) | Derivados bis-(sulfonilamino) para uso en terapia | |
CR11819A (es) | Compuestos de isoindolina 5-sustituidos | |
GT200900283A (es) | "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario". | |
CR10277A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
GT200600366A (es) | Compuestos de imidazol sustituido como inhibidores de ksp | |
ECSP088549A (es) | Nuevos derivados de pirrol fusionado | |
CO6150138A2 (es) | Ciclobuten-1,2-dionas 3,4-di-sustituidas como ligandos de receptores de quimiocinas cxc | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
GT200900192A (es) | Derivados de imidazol como inhibidores de proteina de uso de cinesina (eg-5).- | |
ECSP099442A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
UY28856A1 (es) | Nuevos imidazoles | |
CR11584A (es) | Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina |